José Gustavo Hernández

Dr. José Gustavo Hernández

Hospital Infantil de México Federico Gómez

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2021 in Life
Verified
Journal Article
Open access
PDF file
HMHoracio Marquez-Gonzalez
Horacio Marquez-Gonzalez
JHJosé Gustavo Hernández
José Gustavo Hernández
MVMontserrat Del Valle-Lom
Montserrat Del Valle-Lom
LYLucelli Yáñez-Gutiérrez
Lucelli Yáñez-Gutiérrez
MKMiguel Klünder-Klünder
Miguel Klünder-Klünder
SKSolange Gabriela Koretzky
Solange Gabriela Koretzky
The Fontan procedure (FP) is the standard surgical treatment for Univentricular heart diseases. Over time, the Fontan system fails, leading to pathologies such as protein-losing enteropathy (PLE), plastic bronchitis (PB), and heart failure (HF). FP should be considered as a transitional step to the final treatment: heart transplantation (HT). This systematic review and meta-analysis aims to establish the risk of death following HT according to the presence of FP complications. There was a total of 691 transplanted patients in the 18 articles, immediate survival 88% (n = 448), survival from 1 to 5 years of 78% (n = 427) and survival from 5.1 to 10 years of 69% (n = 208), >10 years 61% (n = 109). The relative risk (RR) was 1.12 for PLE (95% confidence interval [CI] = 0.89–1.40, p = 0.34), 1.03 for HF (0.7–1.51, p = 0.88), 0.70 for Arrhythmias (0.39–1.24, p = 0.22), 0.46 for PB (0.08–2.72, p = 0.39), and 5.81 for CKD (1.70–19.88, p = 0.005). In patients with two or more failures, the RR was 1.94 (0.99–3.81, p = 0.05). After FP, the risk of death after HT is associated with CKD and with the presence of two or more failures.